Solventum price target lowered to $35 from $38 at CIBC
The target implies significant downside, though it is a single analyst opinion rather than a confirmed catalyst.
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
The target implies significant downside, though it is a single analyst opinion rather than a confirmed catalyst.
What happened, with direct paths to the underlying reporting
CIBC cut its Solventum price target to $35, well below the posted price of $82, indicating a sharply bearish analyst view.
Target: $35
Posted price: $82
Analyst firm: CIBC
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.